Evolus Inc. (EOLS)
NASDAQ: EOLS
· Real-Time Price · USD
11.99
0.19 (1.61%)
At close: May 02, 2025, 12:22 PM
Evolus Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 60.16M | 66.22M | 58.96M | 60.67M | 49.32M | 48.68M | 41.05M | 42.99M | 33.22M | 37.16M | 33.23M | 34.66M | 26.68M | 25.4M | 20.58M | 16.92M |
| Product Revenue Growth | -9.15% | +12.31% | -2.81% | +23.01% | +1.32% | +18.60% | -4.52% | +29.42% | -10.62% | +11.85% | -4.13% | +29.91% | +5.04% | +23.42% | +21.59% | n/a |
| Service Revenue | 921K | 687K | 369K | 328K | 696K | 666K | 674K | 658K | 684K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue Growth | +34.06% | +86.18% | +12.50% | -52.87% | +4.50% | -1.19% | +2.43% | -3.80% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| Canada Revenue | 702K | 738K |
| Canada Revenue Growth | -4.88% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 52.51M | 50.15M | 45.12M | 43.06M | 43.33M | 41.17M | 37.38M | 36.73M | 34.79M | 36.88M | 33.44M | 33.28M | 31.68M | 26.47M | 20.68M | 27.39M | 21.94M | 17.55M | 31.3M | 30.29M | 30.9M | 34.89M | 17.52M | 12.22M | 7.21M | 6.25M | 3.47M | 1.65M | 1.15M | 803K | 1.22M | 922K | 989K | 2.56M | 2.56M |
| Selling, General, and Administrative Revenue Growth | +4.69% | +11.15% | +4.80% | -0.62% | +5.23% | +10.14% | +1.78% | +5.56% | -5.64% | +10.27% | +0.49% | +5.03% | +19.69% | +28.03% | -24.52% | +24.84% | +25.02% | -43.92% | +3.35% | -1.98% | -11.45% | +99.17% | +43.34% | +69.54% | +15.38% | +80.21% | +110.12% | +43.35% | +43.34% | -33.91% | +31.78% | -6.77% | -61.38% | 0.00% | n/a |
| Research and Development Revenue | 2.31M | 2.35M | 2.08M | 2.38M | 1.59M | 1.21M | 1.38M | 1.35M | 1.38M | 3.55M | 468K | 423K | 301K | 499K | 841K | 719K | 350K | 145K | 507K | 418K | 693K | 509K | 2.35M | 1.18M | 1.98M | 1.65M | 1.68M | 1.21M | 1.47M | 1.36M | 2.65M | 2.68M | 3.06M | 3.43M | 3.43M |
| Research and Development Revenue Growth | -1.53% | +13.09% | -12.69% | +49.97% | +31.37% | -12.53% | +2.45% | -2.03% | -61.24% | +658.55% | +10.64% | +40.53% | -39.68% | -40.67% | +16.97% | +105.43% | +141.38% | -71.40% | +21.29% | -39.68% | +36.15% | -78.37% | +98.73% | -40.11% | +19.96% | -1.79% | +38.91% | -17.54% | +7.33% | -48.51% | -1.12% | -12.33% | -10.95% | 0.00% | n/a |